DOSE RESPONSE ANALYSIS OF INHALED TREPROSTINIL IN PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE AND ITS EFFECTS ON CLINICAL WORSENING

被引：1
|
作者：
Waxman, Aaron
Nathan, Steven
Fisher, Micah
Ford, H. James
Gagermeier, James
Parambil, Joseph
Raina, Amresh
Zwicke, Dianne
Gerke, Alicia
Shen, Eric
Lee, Dasom
Rao, Youlan
Tapson, Victor
机构：
来源：
CHEST | 2021年 / 160卷 / 04期
关键词：
D O I：
10.1016/j.chest.2021.07.1995
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2279A / 2280A
页数：2
相关论文
共 50 条
  • [31] Practical considerations in the management of inhaled prostacyclin therapy for pulmonary hypertension associated with interstitial lung disease (WHO group 3)
    Lee, Charlie
    Hamlyn, Joan
    Porcelli, Julie
    Schmit, Ann
    [J]. RESPIRATORY MEDICINE, 2022, 196
  • [32] The use of sildenafil to treat pulmonary hypertension associated with interstitial lung disease
    Corte, Tamera J.
    Gatzoulis, Michael A.
    Parfitt, Lisa
    Harries, Carl
    Wells, Athol U.
    Wort, S. John
    [J]. RESPIROLOGY, 2010, 15 (08) : 1226 - 1232
  • [33] Interstitial lung disease and pulmonary hypertension associated with epidermolysis bullosa in an infant
    Doeker, B
    Hussein, A
    Trowitzsch, E
    [J]. KLINISCHE PADIATRIE, 1998, 210 (05): : 340 - 344
  • [34] Pulmonary hypertension in interstitial lung disease: an area of unmet clinical need
    Dhont, Sebastiaan
    Zwaenepoel, Bert
    Vandecasteele, Els
    Brusselle, Guy
    De Pauw, Michel
    [J]. ERJ OPEN RESEARCH, 2022, 8 (04)
  • [35] Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial
    Nathan, Steven D.
    Tapson, Victor F.
    Elwing, Jean
    Rischard, Franz
    Mehta, Jinesh
    Shapiro, Shelley
    Shen, Eric
    Deng, Chunqin
    Smith, Peter
    Waxman, Aaron
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (02) : 198 - +
  • [36] Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension Due to Parenchymal Lung Disease in the INCREASE Trial
    Nathan, S. D.
    Tapson, V. F.
    Elwing, J. M.
    Rischard, F. P.
    Mehta, J. P.
    Shapiro, S.
    Shen, E.
    Edwards, L.
    Smith, P. M.
    Waxman, A. B.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [37] Comparison of Scleroderma Associated Isolated Pulmonary Arterial Hypertension and Pulmonary Hypertension with Concomitant Interstitial Lung Disease
    Hannan, Alexander
    Dweik, Raed
    Highland, Kristin B.
    Heresi, Gustavo
    Tonelli, Adriano
    Messner, William
    Chatterjee, Soumya
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [38] Real-world use of inhaled treprostinil for lung disease-pulmonary hypertension: A protocol for patient evaluation and prescribing
    Johnson, Shelsey W.
    Finlay, Lauren
    Mathai, Stephen C.
    Goldstein, Ronald H.
    Maron, Bradley A.
    [J]. PULMONARY CIRCULATION, 2022, 12 (03)
  • [39] Clinical Characteristics and Survival in Systemic Sclerosis-Related Pulmonary Hypertension Associated With Interstitial Lung Disease
    Launay, David
    Humbert, Marc
    Berezne, Alice
    Cottin, Vincent
    Allanore, Yannick
    Couderc, Louis-Jean
    Bletry, Olivier
    Yaici, Azzedine
    Hatron, Pierre-Yves
    Mouthon, Luc
    Le Pavec, Jerome
    Clerson, Pierre
    Hachulla, Eric
    [J]. CHEST, 2011, 140 (04) : 1016 - 1024
  • [40] PULMONARY HYPERTENSION IN DIFFERENT TYPES OF INTERSTITIAL LUNG DISEASE INCIDENCE ANALYSIS
    Peng, L.
    Dai, H.
    [J]. RESPIROLOGY, 2011, 16 : 321 - 321
12345